Brian represents clients in high-stakes commercial disputes throughout the country, with a focus on antitrust, intellectual property, general commercial and securities litigation. He has served clients in a variety of industries, including media and entertainment, technology, life sciences, and financial services. Brian also maintains an active pro bono practice.
Cooley advised Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, on its successful proxy contest against Deep Track Capital.